SHINGRIX POWDER AND SUSPENSION FOR SUSPENSION FOR INJECTION 50MCG/0.5ML
Product details
Registration number: SIN16079P
Classification: Prescription Only
Active ingredients: Recombinant Varicella Zoster Virus glycoprotein E
Strength: 50mcg/0.5mL
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION
Route: INTRAMUSCULAR
Registrant: GLAXOSMITHKLINE PTE LTD
ATC code: J07BK
HSA approval date: 12 January 2021
Manufacturer(s):
- GlaxoSmithKline Biologicals SA
- GlaxoSmithKline Biologicals s.a.s (Filling and lyophilisation)
- Patheon Italia S.P.A (filling and lyophilisation)
Manufacturing country/countries: BELGIUM; FRANCE; ITALY
What are the HSA registration number and classification for SHINGRIX POWDER AND SUSPENSION FOR SUSPENSION FOR INJECTION 50MCG/0.5ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16079P
Classification: Prescription Only
What active ingredients and strength are recorded for SHINGRIX POWDER AND SUSPENSION FOR SUSPENSION FOR INJECTION 50MCG/0.5ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Recombinant Varicella Zoster Virus glycoprotein E
Strength: 50mcg/0.5mL
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for SHINGRIX POWDER AND SUSPENSION FOR SUSPENSION FOR INJECTION 50MCG/0.5ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION
Route: INTRAMUSCULAR
Who is the recorded registrant for SHINGRIX POWDER AND SUSPENSION FOR SUSPENSION FOR INJECTION 50MCG/0.5ML?
According to the HSA dataset updated 7 August 2026:
Registrant: GLAXOSMITHKLINE PTE LTD
Which manufacturers and countries are listed for SHINGRIX POWDER AND SUSPENSION FOR SUSPENSION FOR INJECTION 50MCG/0.5ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- GlaxoSmithKline Biologicals SA
- GlaxoSmithKline Biologicals s.a.s (Filling and lyophilisation)
- Patheon Italia S.P.A (filling and lyophilisation)
Manufacturing country/countries: BELGIUM; FRANCE; ITALY
Where can I look up SHINGRIX POWDER AND SUSPENSION FOR SUSPENSION FOR INJECTION 50MCG/0.5ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16079P or the exact product name SHINGRIX POWDER AND SUSPENSION FOR SUSPENSION FOR INJECTION 50MCG/0.5ML. The general register link does not preselect this product.
What are the source dates for this SHINGRIX POWDER AND SUSPENSION FOR SUSPENSION FOR INJECTION 50MCG/0.5ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this SHINGRIX POWDER AND SUSPENSION FOR SUSPENSION FOR INJECTION 50MCG/0.5ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16079P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)